2.5.2025 23:06:46 CEST | Thor Medical ASA | Additional regulated information
required to be disclosed under the laws of a member state
Oslo, Norway, 2 May 2025
Reference is made to the stock exchange announcement made by Thor Medical ASA
(the "Company") the Company on 2 May 2025 regarding the grant of restricted
share units ("RSU") to members of the board of directors.
Primary insider notifications pursuant to the market abuse regulation article 19
are attached hereto. This information is required to be disclosed under Section
5-12 of the Securities Trading Act.
CONTACTS
Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440,
brede.ellingseter@thormedical.com
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.
To learn more, visitwww.thormedical.no - http://visitwww.thormedical.no -
https://www.thormedical.no.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18514642/6044/Download%20announce
ment%20as%20PDF.pdf
Jens Gisle Schnelle - Primary insider notifications.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18514642/6041/Jens%20Gisle%20Schn
elle%20-%20Primary%20insider%20notifications.pdf
Mimi K Berdal - Primary insider notifications.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18514642/6042/Mimi%20K%20Berdal%2
0-%20Primary%20insider%20notifications.pdf
Thomas Ramdahl - Primary insider notifications.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18514642/6043/Thomas%20Ramdahl%20
-%20Primary%20insider%20notifications.pdf